AsiaIntervention最新文献

筛选
英文 中文
Complex PCI of the RCA using an anchoring balloon in a circumflex artery. 在环状动脉中使用锚定球囊对 RCA 进行复杂 PCI。
AsiaIntervention Pub Date : 2024-07-26 eCollection Date: 2024-07-01 DOI: 10.4244/AIJ-D-23-00070
Heberto Aquino Bruno, Marco A Alcantara-Meléndez, Juan F García-García, Carlos Roque-Palacios, Martin Cedillo-Urbina, Kevin R Hernandez-Flores
{"title":"Complex PCI of the RCA using an anchoring balloon in a circumflex artery.","authors":"Heberto Aquino Bruno, Marco A Alcantara-Meléndez, Juan F García-García, Carlos Roque-Palacios, Martin Cedillo-Urbina, Kevin R Hernandez-Flores","doi":"10.4244/AIJ-D-23-00070","DOIUrl":"10.4244/AIJ-D-23-00070","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-coated balloon angioplasty for coronary de novo lesions - hype or hope? 药物涂层球囊血管成形术治疗冠状动脉新发病变--炒作还是希望?
AsiaIntervention Pub Date : 2024-07-26 eCollection Date: 2024-07-01 DOI: 10.4244/AIJ-E-24-00002
Bruno Scheller
{"title":"Drug-coated balloon angioplasty for coronary de novo lesions - hype or hope?","authors":"Bruno Scheller","doi":"10.4244/AIJ-E-24-00002","DOIUrl":"10.4244/AIJ-E-24-00002","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter aortic valve replacement in China - a review of the available evidence. 中国经导管主动脉瓣置换术--现有证据综述。
AsiaIntervention Pub Date : 2024-07-26 eCollection Date: 2024-07-01 DOI: 10.4244/AIJ-D-23-00049
Lai Wei, Bin Wang, Ye Yang, Lili Dong, Xiang Chen, Peter Bramlage, Yan Wang
{"title":"Transcatheter aortic valve replacement in China - a review of the available evidence.","authors":"Lai Wei, Bin Wang, Ye Yang, Lili Dong, Xiang Chen, Peter Bramlage, Yan Wang","doi":"10.4244/AIJ-D-23-00049","DOIUrl":"10.4244/AIJ-D-23-00049","url":null,"abstract":"<p><p>This paper discusses aortic stenosis (AS) in China, emphasising the role of transcatheter aortic valve replacement (TAVR) in treating AS in an ageing population. AS characteristics, its treatment and the clinical outcomes of transfemoral TAVR in Chinese patients are described via a systematic review. AS affects >1% of the Chinese population aged ≥65 years, with degenerative AS predominating over rheumatic AS among this age group. Chinese patients often have high aortic valve (AV) calcification with bicuspid AV morphology. In 2021, 38,000 surgical aortic valve replacements (SAVR) were reported in China, while the number of TAVR increased from 293 in 2017 to 7,357 in 2021. There are four self-expanding valves and one balloon-expandable SAPIEN 3 valve available in China. Among them, the Venus A-Valve is the most studied and widely used, whereas limited data are available for VitaFlow, TaurusOne, and SAPIEN 3. Notably, 10.0-16.5% of Venus A-Valve recipients and 0.2% of SAPIEN 3 recipients required multiple valve implantations. The rates of 30-day paravalvular leakage were 0-11.7%/0% for Venus A-Valve, 2.0%/0% for VitaFlow, and 0%/0% for SAPIEN 3, for moderate and severe leakage, respectively. Thirty-day all-cause mortality rates were 3.7-10.0% for Venus A-Valve, 0.9% for VitaFlow, and 0-3.2% for SAPIEN 3. One-year all-cause mortality rates were 5.9-13.6% for Venus A-Valve, 0-4.5% for VitaFlow, 6.7% for TaurusOne, and 6.2% for SAPIEN 3. The Venus A-Valve indicated lower 30-day permanent pacemaker implantation (PPI) rates (7.4-20.5%) than VitaFlow and TaurusOne. Outcomes for patients with bicuspid or tricuspid aortic valves were similar. AS is rising among the elderly Chinese population; SAVR is common, and TAVR is increasing. Limited device comparisons exist, but the Venus A-Valve seems to have lower PPI rates, and SAPIEN 3 has low 30-day mortality in China.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261658/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stent infections: elephant in the room. 支架感染:房间里的大象。
AsiaIntervention Pub Date : 2024-07-26 eCollection Date: 2024-07-01 DOI: 10.4244/AIJ-E-24-00003
Anil Dhall, Kirti Punamiya
{"title":"Stent infections: elephant in the room.","authors":"Anil Dhall, Kirti Punamiya","doi":"10.4244/AIJ-E-24-00003","DOIUrl":"https://doi.org/10.4244/AIJ-E-24-00003","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11261652/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141790171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A curious case of type IV dual LAD presenting with ST-elevation myocardial infarction. 一例以 ST 段抬高型心肌梗死为特征的 IV 型双 LAD 病例。
AsiaIntervention Pub Date : 2024-02-29 eCollection Date: 2024-02-01 DOI: 10.4244/AIJ-D-23-00046
Sushant Kharel, Kunjang Sherpa, Sanjay Singh Kc, Dipanker Prajapati, Rikesh Tamrakar
{"title":"A curious case of type IV dual LAD presenting with ST-elevation myocardial infarction.","authors":"Sushant Kharel, Kunjang Sherpa, Sanjay Singh Kc, Dipanker Prajapati, Rikesh Tamrakar","doi":"10.4244/AIJ-D-23-00046","DOIUrl":"10.4244/AIJ-D-23-00046","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10902655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in medical writing. 医学写作中的人工智能。
AsiaIntervention Pub Date : 2024-02-29 eCollection Date: 2024-02-01 DOI: 10.4244/AIJ-E-23-00005
James Howard, Hoi Ching Cheung
{"title":"Artificial intelligence in medical writing.","authors":"James Howard, Hoi Ching Cheung","doi":"10.4244/AIJ-E-23-00005","DOIUrl":"10.4244/AIJ-E-23-00005","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conduction disturbance following valve-in-valve implantation in a 19 mm surgical valve: impact on implantation depth in an ex vivo experiment. 在 19 毫米手术瓣膜中植入瓣膜后的传导干扰:体内外实验中植入深度的影响。
AsiaIntervention Pub Date : 2024-02-29 eCollection Date: 2024-02-01 DOI: 10.4244/AIJ-D-23-00028
Tomoaki Kobayashi, Kensuke Takagi, Atsushi Okada, Teruo Noguchi
{"title":"Conduction disturbance following valve-in-valve implantation in a 19 mm surgical valve: impact on implantation depth in an ex vivo experiment.","authors":"Tomoaki Kobayashi, Kensuke Takagi, Atsushi Okada, Teruo Noguchi","doi":"10.4244/AIJ-D-23-00028","DOIUrl":"10.4244/AIJ-D-23-00028","url":null,"abstract":"","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variability in research culture across busy catheterisation labs in the Asia-Pacific region. 亚太地区繁忙导管实验室的科研文化差异。
AsiaIntervention Pub Date : 2024-02-29 eCollection Date: 2024-02-01 DOI: 10.4244/AIJ-D-23-00005
Manish Narang, Aseem Saxena, Ramneek Kaur, Hanumanthu Reddy Gopa, Nick E J West
{"title":"Variability in research culture across busy catheterisation labs in the Asia-Pacific region.","authors":"Manish Narang, Aseem Saxena, Ramneek Kaur, Hanumanthu Reddy Gopa, Nick E J West","doi":"10.4244/AIJ-D-23-00005","DOIUrl":"10.4244/AIJ-D-23-00005","url":null,"abstract":"<p><strong>Background: </strong>Information related to research culture in the busy catheterisation (cath) labs across the Asia-Pacific (APAC) region is sparse.</p><p><strong>Aims: </strong>The aims of this study were to examine the variability in research culture in busy cath labs in the APAC region and to propose a roadmap for hospitals to develop in-house research capabilities in conjunction with industry and academia.</p><p><strong>Methods: </strong>Data related to research practices in the APAC region were collected from busy cath labs (at least 250 angioplasty/year) and analysed. Results were shared with research experts to understand the challenges in institutional research and create a roadmap for hospitals to develop research capabilities.</p><p><strong>Results: </strong>A total of 220 respondents from 62 cath labs (88.6%) across 13 APAC countries participated in the survey. A wide variation was noted in research culture across APAC countries. Well-established infrastructure was reported in Australia, New Zealand, South Korea, Singapore, and Japan. Large multicentre trials were common in South Korea, while routine follow-ups were common in Japan. Linking medical records across hospitals/states was considered challenging. Research exposure and training were limited in the APAC region. The experts suggested a roadmap, including creating a conducive regulatory environment, forming synergistic goals, training programs for the professionals involved in research, and leveraging best practices, for improving the research culture in APAC.</p><p><strong>Conclusions: </strong>Clinical research in cardiology has grown significantly in the APAC region, with a huge research potential in China and India. Implementing measures to improve research training and involvement of the industry will boost the research culture in the APAC region.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of cerebral embolic protection in transcatheter aortic valve implantation: an updated meta-analysis. 经导管主动脉瓣植入术中脑栓塞保护的安全性和有效性:最新荟萃分析。
AsiaIntervention Pub Date : 2024-02-29 eCollection Date: 2024-02-01 DOI: 10.4244/AIJ-D-23-00022
Nicholas Tan, Gao Fei, Mohammed Rizwan Amanullah, Soo Teik Lim, Zameer Abdul Aziz, Sivaraj Govindasamy, Victor Tar Toong Chao, See Hooi Ewe, Kay Woon Ho, Jonathan Yap
{"title":"Safety and efficacy of cerebral embolic protection in transcatheter aortic valve implantation: an updated meta-analysis.","authors":"Nicholas Tan, Gao Fei, Mohammed Rizwan Amanullah, Soo Teik Lim, Zameer Abdul Aziz, Sivaraj Govindasamy, Victor Tar Toong Chao, See Hooi Ewe, Kay Woon Ho, Jonathan Yap","doi":"10.4244/AIJ-D-23-00022","DOIUrl":"10.4244/AIJ-D-23-00022","url":null,"abstract":"<p><strong>Background: </strong>The use of cerebral embolic protection devices during transcatheter aortic valve implantation (TAVI) reveals conflicting data.</p><p><strong>Aims: </strong>This updated meta-analysis aims to evaluate the efficacy and safety of the SENTINEL Cerebral Protection System.</p><p><strong>Methods: </strong>A literature search for relevant studies up to September 2022 was performed. Study outcomes were divided based on time period - overall (up to 30 days) and short (≤7 days). The outcomes studied include stroke (disabling, non-disabling), mortality, neuroimaging findings, transient ischaemic attack, acute kidney injury and major vascular and bleeding complications.</p><p><strong>Results: </strong>A total of 15 studies involving 294,134 patients were included. Regarding overall outcomes, significant reductions were noted for mortality (odds ratio [OR] 0.60, 95% confidence interval [CI]: 0.41-0.88; p=0.008), all stroke (OR 0.64, 95% CI: 0.46-0.88; p=0.006) and disabling stroke (OR 0.42, 95% CI: 0.23-0.74; p=0.003) using the SENTINEL device. No significant differences were noted for other outcomes. There was significant heterogeneity across the studies for mortality (p=0.013) and all stroke (p=0.003). Including only randomised data (n=4), there was only significant reduction in the incidence of disabling stroke (OR 0.39, 95% CI: 0.17-0.89; p=0.026) in the SENTINEL group. In studies reporting ≤7-day outcomes (n=8), use of the SENTINEL device demonstrated significantly lower rates of all stroke (p<0.001), disabling stroke (p<0.001) and major bleeding complications (p=0.02). No differences in neuroimaging outcomes were noted.</p><p><strong>Conclusions: </strong>In this updated meta-analysis, use of the SENTINEL Cerebral Protection System was associated with lower rates of mortality, all stroke and disabling stroke, although significant heterogeneity was noted for mortality and all stroke. Including exclusively randomised data, there was only significant reduction in the incidence of disabling stroke. No significant adverse outcomes with device use were noted.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of a minimalistic balloon aortic valvuloplasty strategy in a centre without heart surgery. 在一个没有心脏外科手术的中心采用极简球囊主动脉瓣成形术的有效性和安全性。
AsiaIntervention Pub Date : 2024-02-29 eCollection Date: 2024-02-01 DOI: 10.4244/AIJ-D-23-00041
Matteo Bruno, Gianmarco Iannopollo, Laura Sofia Cardelli, Alessandro Capecchi, Valerio Lanzilotti, Roberto Verardi, Chiara Pedone, Giampiero Nobile, Gianni Casella
{"title":"Efficacy and safety of a minimalistic balloon aortic valvuloplasty strategy in a centre without heart surgery.","authors":"Matteo Bruno, Gianmarco Iannopollo, Laura Sofia Cardelli, Alessandro Capecchi, Valerio Lanzilotti, Roberto Verardi, Chiara Pedone, Giampiero Nobile, Gianni Casella","doi":"10.4244/AIJ-D-23-00041","DOIUrl":"10.4244/AIJ-D-23-00041","url":null,"abstract":"<p><strong>Background: </strong>Balloon aortic valvuloplasty (BAV) is a palliative tool for patients with symptomatic severe aortic stenosis (AS) at prohibitive risk for surgery or as a bridge to surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). BAV is traditionally performed in hospitals with onsite cardiac surgery due to its potential complications.</p><p><strong>Aims: </strong>The aim of this study was to evaluate the safety of BAV procedures performed by trained high-volume operators in a centre without onsite surgery and to assess the effect of a minimalistic approach to reduce periprocedural complications.</p><p><strong>Methods: </strong>From 2016 to 2021, 187 BAV procedures were performed in 174 patients. Patients were elderly (mean age: 85.0±5.4 years) and had high-risk (mean European System for Cardiac Operative Risk Evaluation score [EuroSCORE] II: 10.1±9.9) features. According to the indications, 4 cohorts were identified: 1) bridge to TAVR (n=98; 56%); 2) bridge to SAVR (n=8; 5%); 3) cardiogenic shock (n=11; 6%); and 4) palliation (n=57; 33%). BAV procedures were performed using the standard retrograde technique via femoral access in 165 patients (95%), although radial access was used in 9 patients (5%). Ultrasound-guided vascular puncture was performed in 118 patients (72%) and left ventricular pacing was administered through a stiff guidewire in 105 cases (60%).</p><p><strong>Results: </strong>BAV safety was confirmed by 1 periprocedural death (0.6%), 1 intraprocedural stroke (0.6%), 2 major vascular complications (1%) and 9 minor vascular complications (5%). Nine cases of in-hospital mortality occurred (5%), predominantly in patients with cardiogenic shock.</p><p><strong>Conclusions: </strong>BAV is a safe procedure that can be performed in centres without onsite cardiac surgery using a minimalistic approach that can reduce periprocedural complications.</p>","PeriodicalId":72310,"journal":{"name":"AsiaIntervention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10900243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139998816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信